Skip to main content
Faculty and Staff

Center for Pharmacogenomics and Molecular Therapy

The Center's mission is to integrate research, teaching and service to maximize drug efficacy and minimize toxicity through a genomically-guided approach in drug discovery and development, therapeutic design, and post-clinical surveillance.

 

The goal of the Center is to promote translational research from laboratory to bedside and from laboratory to retail store.

The Center serves as a platform to:

Attract and compete for large research funds.
Develop collaborative projects with pharmaceutical companies.
Refine both undergraduate and graduate curricula with research
and market-orientated priorities.


The Center has 30 members from six Colleges, whose research focuses are aligned
with the theme of the Center.

Some of the members are well-established investigators with NIH R01 funding, others are still in the early stage of their careers.

 

Internal Executive Board
Bingfang Yan, Professor and Director
URI College of Pharmacy

Peter Alfonso, Vice President for Research and Economic Development
University of Rhode Island

Clinton O. Chichester, Professor & Chairman
URI College of Pharmacy

Tom Manfredi, Professor
URI College of Human Science & Services

Gongqing Sun, Associate Professor
URI College of Environmental & Life Sciences

Frederick Vetter, Assistant Professor
URI College of Engineering

Mark Wood, Professor
URI College of Arts & Sciences

External Advisory Committee
John Y. Chiang, Professor & Chairman
NE Ohio Universities, College of Medicine

William J. Jusko, Professor & Chairman
State Univ. New York at Buffalo, Pharmacy

Edward T. Morgan, Professor
Emory University, School of Medicine

Michael J. Morin, Vice President
Pfizer, Global Research & Development

David J. Waxman, Professor
Boston University, School of Medicine

 

Spearhead research in life sciences at URI
The Center has been established to provide leadership to the University’s entire life science research enterprise.

Develop state-of-the-art
core-facilities
The Center, along with other programs such as INBRE and EPSCoR, will continue to develop the University’s core research facilities.

Actively and cooperatively seek extramural research funding
Concrete measures are being taken to increase the competitiveness for seeking extramural funding. These measures include financial support, mentoring activities, data sharing, and proposal development assistance.

Refine undergraduate
and graduate curricula
The Center serves as an educational platform for the integration of existing curricula and development of new programs on pharmaco­genomics and molecular therapy.

 

     
     

 

 

 

 

Heading 3

Insert Third Column Content Here